The Genomics of Hypertension

Chana Yagil, Yoram Yagil

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

This chapter focuses on how genomics has affected the understanding of the predisposition to hypertension, its ability to screen, diagnose, and determine the prognosis of patients, and its applicability to the monitoring of hypertension. The pathophysiology underlying hypertension remains unresolved even with intensive research in human populations and experimental animal models. In a majority of cases, hypertension is thought to result from an interaction of genes with environmental factors. In only a small number of cases, genetic dissection of hypertension has uncovered single gene mutations that lead to the development of monogenic forms of disease. The complexity of hypertension is illustrated by Guyton's traditional model of cardiovascular dynamics in which multiple circuits of physiological mechanisms act in conjunction with one another to cause hypertension. Unraveling the huge complexity of the pathophysiology underlying the most common form of hypertension is a difficult task, which still remains far from being completed. Genomics, along with physiological genomics, aims to provide more detailed insight into the mechanisms underlying essential hypertension where traditional physiology has failed at large. This, in turn, will facilitate a more rational therapeutic approach to the treatment of the disease, as well as development of new drugs for hypertension. © 2010

Original languageEnglish
Title of host publicationEssentials of Genomic and Personalized Medicine
PublisherElsevier Inc.
Pages259-268
Number of pages10
ISBN (Print)9780123749345
DOIs
StatePublished - 1 Dec 2010

Fingerprint

Dive into the research topics of 'The Genomics of Hypertension'. Together they form a unique fingerprint.

Cite this